$10.29
0.090.88%
At Close: -
$10.29
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/14/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $101.31M | Get Alert |
04/26/2024 | OPRX | OptimizeRx | Q1 | 2024 | — | — | — | $18.50M | $19.20M | $17.03M | Get Alert |
04/16/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $104.73M | Get Alert |
03/11/2024 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $70.00M | — | $69.62M | Get Alert |
03/11/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $100.00M | — | $110.41M | Get Alert |
01/09/2024 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $70.00M | — | $68.78M | Get Alert |
01/09/2024 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $110.00M | — | $110.29M | Get Alert |
11/06/2023 | OPRX | OptimizeRx | FY | 2024 | — | — | — | $110.00M | — | $75.92M | Get Alert |
11/06/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $63.00M | $65.00M | $60.51M | Get Alert |
10/12/2023 | OPRX | OptimizeRx | Q3 | 2023 | — | — | — | $15.20M | $15.50M | $14.26M | Get Alert |
05/10/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $68.69M | — | $68.64M | Get Alert |
03/08/2023 | OPRX | OptimizeRx | FY | 2023 | — | — | — | $68.69M | — | $77.80M | Get Alert |
03/08/2023 | OPRX | OptimizeRx | Q1 | 2023 | — | — | — | $11.50M | $13.00M | $16.15M | Get Alert |
11/08/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $62.00M | $68.00M | $64.05M | Get Alert |
08/09/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $62.00M | $68.00M | $81.44M | Get Alert |
05/04/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.83M | Get Alert |
02/24/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.61M | Get Alert |
02/15/2022 | OPRX | OptimizeRx | Q4 | 2021 | — | — | — | $20.30M | $20.30M | $20.24M | Get Alert |
02/15/2022 | OPRX | OptimizeRx | FY | 2022 | — | — | — | $80.00M | $85.00M | $81.59M | Get Alert |
01/25/2021 | OPRX | OptimizeRx | Q4 | 2020 | — | — | — | $16.00M | $16.00M | $11.10M | Get Alert |
01/25/2021 | OPRX | OptimizeRx | FY | 2020 | — | — | — | $43.00M | $43.00M | $37.99M | Get Alert |
10/13/2020 | OPRX | OptimizeRx | Q3 | 2020 | — | — | — | $10.00M | — | $9.10M | Get Alert |
There have been no specific sales or earnings guidance reported for OptimizeRx in recent months.
Browse guidance and forecast on all stocks.